Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods

被引:31
作者
Jones, RN
Anderegg, TR
Swenson, JM
机构
[1] JMI Labs Inc, JONES Grp, N Liberty, IA 52317 USA
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
[3] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
D O I
10.1128/JCM.43.2.925-927.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
An eight-laboratory study addressed the urgent need for quality control (QC) ranges for susceptibility determination when testing colistin (polymyxin E) and polymyxin B, two polycationic peptide antimicrobial agents, against multidrug-resistant gram-negative bacilli. For Escherichia coli ATCC 259221, the QC ranges were as follows: for colistin, 0.25 to 1 mug/ml (11 to 17 mm), and for polymyxin B, 0.25 to 2 mug/ml (13 to 19 mm). For Pseudomonas aeruginosa ATCC 27853, the QC ranges were as follows: for colistin, 0.25 to 2 mug/ml (11 to 17 mm), and for polymyxin B, 0.25 to 2 mug/ml (14 to 18 mm). More than 97% of all reported QC results were within these proposed ranges.
引用
收藏
页码:925 / 927
页数:3
相关论文
共 15 条
[1]  
[Anonymous], DEV IN VITR SUSC TES
[2]  
[Anonymous], [No title captured]
[3]   SODIUM SULPHOMETHYL DERIVATIVES OF POLYMYXINS [J].
BARNETT, M ;
BUSHBY, SRM ;
WILKINSON, S .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1964, 23 (03) :552-+
[4]   Polymyxin B sulfate and colistin: Old antibiotics for emerging multiresistant gram-negative bacteria [J].
Evans, ME ;
Feola, DJ ;
Rapp, RP .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (09) :960-967
[5]   Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: Review of available interpretative criteria and quality control guidelines [J].
Gales, AC ;
Reis, AO ;
Jones, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) :183-190
[6]   Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii [J].
Levin, AS ;
Barone, AA ;
Penço, J ;
Santos, MV ;
Marinho, IS ;
Arruda, EAG ;
Manrique, EI ;
Costa, SF .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) :1008-1011
[7]   Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis [J].
Li, J ;
Coulthard, K ;
Milne, R ;
Nation, RL ;
Conway, S ;
Peckham, D ;
Etherington, C ;
Turnidge, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (06) :987-992
[8]  
*NAT COMM CLIN LAB, 1982, M2A2S2 NAT COMM CLIN
[9]  
*NAT COMM CLIN LAB, 1980, PSM7 NAT COMM CLIN L
[10]  
*NAT COMM CLIN LAB, 2005, M100S15 NAT COMM CLI